DK3873432T3 - Tetracyclinkomplekser med vedvarende aktivitet - Google Patents

Tetracyclinkomplekser med vedvarende aktivitet Download PDF

Info

Publication number
DK3873432T3
DK3873432T3 DK19804637.7T DK19804637T DK3873432T3 DK 3873432 T3 DK3873432 T3 DK 3873432T3 DK 19804637 T DK19804637 T DK 19804637T DK 3873432 T3 DK3873432 T3 DK 3873432T3
Authority
DK
Denmark
Prior art keywords
sustained activity
tetracycline
complexes
tetracycline complexes
sustained
Prior art date
Application number
DK19804637.7T
Other languages
English (en)
Inventor
Andreas Kiesow
Mirko Buchholz
Sandra Sarembe
Sigrun Eick
Karsten Mäder
Martin Kirchberg
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP18203133.6A external-priority patent/EP3646852A1/en
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of DK3873432T3 publication Critical patent/DK3873432T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Machine Translation (AREA)
DK19804637.7T 2018-10-29 2019-10-29 Tetracyclinkomplekser med vedvarende aktivitet DK3873432T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18203133.6A EP3646852A1 (en) 2018-10-29 2018-10-29 Tetracycline complexes with sustained activity
EP19193328 2019-08-23
PCT/EP2019/079566 WO2020089249A1 (en) 2018-10-29 2019-10-29 Tetracycline complexes with sustained activity

Publications (1)

Publication Number Publication Date
DK3873432T3 true DK3873432T3 (da) 2022-12-19

Family

ID=68581748

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19804637.7T DK3873432T3 (da) 2018-10-29 2019-10-29 Tetracyclinkomplekser med vedvarende aktivitet

Country Status (14)

Country Link
US (1) US12539333B2 (da)
EP (1) EP3873432B1 (da)
JP (1) JP7506679B2 (da)
KR (1) KR20210086654A (da)
CN (1) CN113557008A (da)
AU (1) AU2019370918B2 (da)
BR (1) BR112021007969A2 (da)
CA (1) CA3112910A1 (da)
DK (1) DK3873432T3 (da)
ES (1) ES2934605T3 (da)
MY (1) MY203238A (da)
PH (1) PH12021550474A1 (da)
PL (1) PL3873432T3 (da)
WO (1) WO2020089249A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116262108A (zh) * 2021-12-13 2023-06-16 万全万特制药（厦门）有限公司 一种盐酸沙林环素口服片剂及其制备方法
CN119881176A (zh) * 2025-03-27 2025-04-25 苏州方昆医药科技有限公司 一种hplc-ms/ms法检测血浆中沙瑞环素的方法

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4685883A (en) 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
JPH0234325B2 (ja) * 1985-11-22 1990-08-02 Sansutaa Kk Shishushitsukanchiryoyososeibutsu
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US5000886A (en) 1987-05-26 1991-03-19 American Cyanamid Company Silicone-hardened pharmaceutical microcapsules and process of making the same
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324520A (en) 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5236355A (en) 1988-12-22 1993-08-17 American Cyanamid Company Apparatus for the treatment of periodontal disease
US5290271A (en) 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US5059123A (en) 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
WO1992000718A1 (en) 1990-07-03 1992-01-23 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5620700A (en) 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
US5228101A (en) 1992-03-02 1993-07-13 Motorola, Inc. Electrical to optical links using metalization
US5447725A (en) 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
JP4259610B2 (ja) 1994-04-08 2009-04-30 キューエルティー・ユーエスエイ・インコーポレーテッド 液体デリバリー組成物
US5612052A (en) 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
CN1126537C (zh) 1996-05-23 2003-11-05 株式会社三养社 可局部给药,可生物降解和持续释放的用于治疗牙周炎的药物组合物及其制备方法
US6123957A (en) 1997-07-16 2000-09-26 Jernberg; Gary R. Delivery of agents and method for regeneration of periodontal tissues
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
KR100252699B1 (ko) 1998-03-17 2000-12-01 강재헌 치주염 치료용 미노사이클린 조성물
US6296831B1 (en) 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US20040208906A1 (en) 1999-07-12 2004-10-21 Daiichi Suntory Pharma Co., Ltd. Pharmaceutical composition for topical administration
US6946118B1 (en) 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
KR100416242B1 (ko) 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
ATE355824T1 (de) 2000-01-11 2007-03-15 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
IL135061A0 (en) 2000-03-14 2001-05-20 Ahron Jodaikin Strategic targeted fluoridation and chemical treatment of teeth
WO2001092288A2 (en) 2000-05-31 2001-12-06 Mayo Foundation For Medical Education And Research Cobalamin compounds useful as antibiotic agents and as imaging agents
EP1339438B1 (en) 2000-11-29 2005-10-19 Allergan Inc. Preventing transplant rejection in the eye
JP4202656B2 (ja) 2002-02-19 2008-12-24 サンスター株式会社 局所投与型徐放性軟膏
US6682348B2 (en) 2002-03-29 2004-01-27 Orapharma, Inc. Dispensing apparatus and cartridge
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
AU2003256284A1 (en) 2002-06-20 2004-01-06 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
AU2003243607A1 (en) 2002-06-20 2004-01-06 Royer Biomedical, Inc. Resorbable matrices with coatings for delivery of bioactive compounds
AU2003256496A1 (en) 2002-07-12 2004-02-02 The Research Foundation Of State University Of New York Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
CA2501614A1 (en) 2002-10-07 2004-04-22 Orapharma, Inc. Mucoadhesive tetracycline formulations
ES2534827T3 (es) 2003-04-07 2015-04-29 Supernus Pharmaceuticals, Inc. Formulaciones de tetraciclinas en dosis única diaria
JP2006523703A (ja) 2003-04-14 2006-10-19 シャイア ラボラトリーズ，インコーポレイテッド 吸収ウィンドウ問題を克服するための、活性剤をバッカルまたは舌下の位置から放出する薬学的組成物
CA2527664A1 (en) 2003-05-30 2004-12-16 Alza Corporation Implantable elastomeric depot compositions, uses thereof and method of manufacturing
CN103040773A (zh) 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
AU2004313245B2 (en) 2003-12-30 2011-04-14 Durect Corporation Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
US8163030B2 (en) 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
GB2414668B (en) 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
EP1604693A1 (en) 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
WO2006002365A2 (en) 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
US20060009839A1 (en) 2004-07-12 2006-01-12 Scimed Life Systems, Inc. Composite vascular graft including bioactive agent coating and biodegradable sheath
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
AU2006206359B2 (en) 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
US20070059310A1 (en) 2005-05-03 2007-03-15 Karel Steven J Therapeutic combination compositions and methods of using same
US20060252049A1 (en) 2005-05-04 2006-11-09 Shuler Richard O Growth-promoting and immunizing subcutaneous implant
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
MX350380B (es) 2006-05-09 2017-09-05 SpecGx LLC Formas de dosificacion solida de liberacion modificada en el orden de cero.
JP5630998B2 (ja) 2006-05-15 2014-11-26 マサチューセッツ インスティテュート オブ テクノロジー 機能的粒子のためのポリマー
US20080102127A1 (en) 2006-10-26 2008-05-01 Gao Hai Y Hybrid lipid-polymer nanoparticulate delivery composition
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
AU2008231033B2 (en) 2007-03-23 2012-08-30 Molecular Research Center, Inc. Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
WO2008121107A1 (en) 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20090004281A1 (en) 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
CN101288673A (zh) 2007-09-30 2008-10-22 西北工业大学 一种盐酸米诺环素微球及其制备方法以及在制药中的应用
US8974814B2 (en) 2007-11-12 2015-03-10 California Institute Of Technology Layered drug delivery polymer monofilament fibers
EP2067494A1 (en) 2007-12-04 2009-06-10 Charité-Universitätsmedizin Berlin Sheet or tubular structure consisting of elastic biocompatible material and its use
US7976489B2 (en) 2007-12-04 2011-07-12 Orapharma, Inc. Device for delivering medicinal implants
BRPI0915885A2 (pt) 2008-07-09 2015-11-03 Univ Nebraska micelas funcionais para a liberação direcionada de substâncias químicas em tecido duro
WO2010046932A2 (en) 2008-10-21 2010-04-29 Jubilant Organosys Limited Extended release pharmaceutical composition of minocycline and process thereof
WO2010065317A1 (en) 2008-12-02 2010-06-10 Orapharma, Inc. Medicinal implant device and cartridge
US8951546B2 (en) 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
WO2010088682A2 (en) 2009-02-02 2010-08-05 Medtronic, Inc. Composite antimicrobial accessory including a membrane layer and a porous layer
CA2756072A1 (en) 2009-03-30 2010-10-14 Cerulean Pharma Inc. Polymer-agent conjugates, particles, compositions, and related methods of use
WO2010144849A2 (en) 2009-06-11 2010-12-16 Medtronic, Inc. Dissolvable pharmaceutical implant
CN101822650B (zh) 2010-04-28 2012-06-20 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 一种盐酸米诺环素缓释片及其制备方法
KR101799304B1 (ko) 2010-05-12 2017-11-20 렘펙스 파머수티클스 인코퍼레이티드 테트라사이클린 조성물
PT105116B (pt) 2010-05-14 2012-10-16 Hovione Farmaciencia S A Novas partículas de tetraciclina e agente protector.
CN101940560A (zh) 2010-09-16 2011-01-12 孙卫东 一种盐酸米诺环素缓释片及其不同规格的制备方法
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
AU2011326417A1 (en) 2010-11-12 2013-05-09 Tyrx, Inc. Anchorage devices comprising an active pharmaceutical ingredient
KR101319420B1 (ko) 2011-03-18 2013-10-17 한남대학교 산학협력단 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템
US20120244491A1 (en) 2011-03-22 2012-09-27 Remigio Piergallini Device and method for teeth brightening
US20130004651A1 (en) 2011-07-01 2013-01-03 Patty Fu-Giles Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials
CN103827177B (zh) 2011-07-22 2016-02-10 伊诺科雷技术有限公司 用于生物活性化合物的受控释放的生物可降解的、半结晶的、相分离的、热塑性多嵌段共聚物
US20160038645A1 (en) 2012-07-27 2016-02-11 Association For The Advancement Of Tissue Engineering And Cell Based Technologies And Therap Polymeric mesh with selective permeability, for the repair and regeneration of tissues
CA2885334C (en) 2012-11-14 2016-03-08 Orthopaedic Innovation Centre Inc. Antimicrobial articles produced by additive manufacturing
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
US9498539B2 (en) 2012-12-27 2016-11-22 Molly Sandra Shoichet Affinity-based controlled release system
CN103356910A (zh) 2013-06-14 2013-10-23 沈阳创达技术交易市场有限公司 一种用于治疗痱子的药物
WO2015021387A2 (en) 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
GB201314312D0 (en) 2013-08-09 2013-09-25 Regentec Ltd Composition and delivery system
US9402701B2 (en) 2013-10-22 2016-08-02 Profounda, Inc Positionable delivery device and method
US9872881B2 (en) 2013-11-01 2018-01-23 The Brigham And Women's Hospital, Inc. Bone and metal targeted polymeric nanoparticles
CN105431178A (zh) 2013-11-08 2016-03-23 泰尔克斯公司 用于防止手术切口部位感染的抗微生物组合物及方法
CN106456835A (zh) 2014-03-25 2017-02-22 整形外科创新中心公司 增材制造制备的抗菌制品
KR101534522B1 (ko) 2014-09-12 2015-07-07 주식회사 웰나노스 치과용 약물 방출 생분해성 섬유 칩의 제조방법
PT110699B (pt) 2015-02-13 2021-06-30 Hovione Farm Sa Nova forma polimórfica de minociclina base e processos para a sua preparação
PT108223B (pt) 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
US11103517B2 (en) * 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
WO2017066458A1 (en) 2015-10-15 2017-04-20 Tepha, Inc. Implantable fastener for attachment of a medical device to tissue
KR101785930B1 (ko) 2015-12-30 2017-10-16 주식회사 쿼드메디슨 수분 환경에서 변형 및 변성 억제를 위한 마이크로 니들 및 그 제작 방법
CN105534941A (zh) 2016-01-04 2016-05-04 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片及其制备方法
KR101956444B1 (ko) 2016-03-07 2019-03-08 성균관대학교산학협력단 자가 조립 나노입자 방출형 용해성 마이크로니들 구조체 및 그 제조방법
US10939901B2 (en) 2016-05-04 2021-03-09 Medtronic, Inc. Customizable anchorage devices and methods of use
CN109562561B (zh) 2016-09-07 2021-01-12 宝洁公司 聚合物材料和由其制成的制品
US20200061239A1 (en) 2016-09-21 2020-02-27 Orthopaedic Innovation Centre Inc. Antimicrobial articles produced by additive manufacturing
CN109982730A (zh) 2016-09-28 2019-07-05 胡姬医疗科技有限公司 用于植入物的弹性生物可吸收包装物
US10822454B2 (en) 2016-12-02 2020-11-03 University Of Massachusetts Biodegradable amphiphilic shape memory polymers and compositions and methods thereof
EP3501496A1 (en) 2017-12-22 2019-06-26 Cosmo Technologies Ltd. Liquid delivery composition
CA3129056A1 (en) 2018-02-21 2019-08-29 Aron H. BLAESI Expanding structured dosage form
CN108324700A (zh) * 2018-04-07 2018-07-27 青岛润博特生物科技有限公司 一种肠溶缓释土霉素钙预混剂及其制备方法
WO2019213298A1 (en) 2018-05-01 2019-11-07 Texas Tech University System Tailorable medicinally coated floss for the treatment of gum disease
US20220362381A1 (en) 2019-02-21 2022-11-17 Bambu Vault Llc Remotely triggered therapy
US20200375935A1 (en) 2019-05-29 2020-12-03 Gary R. Jernberg Enhanced delivery of a hydrophobic agent in the oral cavity by coupling to a hydrophilic agent with cellular activity
KR20220061106A (ko) 2019-08-02 2022-05-12 코이트 헬스 오와이 전신적으로 적용하는 항생제의 항균 작용을 강화하는 방법
WO2021087179A1 (en) 2019-10-29 2021-05-06 The Regents Of The University Of California Periodontal micropatch and uses thereof
CN112807272A (zh) 2019-10-30 2021-05-18 江苏集萃新型药物制剂技术研究所有限公司 一种用于牙周组织的药物递送方法
WO2021191273A1 (en) 2020-03-24 2021-09-30 Hovione Scientia Limited Compositions for use in treating meibomian gland dysfunction
CN111773179A (zh) 2020-08-07 2020-10-16 常州市第四制药厂有限公司 一种盐酸米诺环素软膏及制备方法

Also Published As

Publication number Publication date
JP7506679B2 (ja) 2024-06-26
PH12021550474A1 (en) 2021-11-22
CA3112910A1 (en) 2020-05-07
WO2020089249A1 (en) 2020-05-07
EP3873432B1 (en) 2022-11-23
US20210401996A1 (en) 2021-12-30
EP3873432A1 (en) 2021-09-08
BR112021007969A2 (pt) 2021-07-27
PL3873432T3 (pl) 2023-02-27
AU2019370918B2 (en) 2024-10-31
CN113557008A (zh) 2021-10-26
KR20210086654A (ko) 2021-07-08
JP2022513388A (ja) 2022-02-07
US12539333B2 (en) 2026-02-03
ES2934605T3 (es) 2023-02-23
MY203238A (en) 2024-06-19
AU2019370918A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
DK3643284T3 (da) Plejeseng
DK3788912T3 (da) Stolearrangement
DK3778573T3 (da) Forbindelse med anticanceraktivitet
EP3989891C0 (en) CRYOCABIN LAYOUT
EP3772265C0 (de) Hackvorrichtung
EP4051540A4 (en) TRUCK BOARD SLIDE ASSEMBLY
EP3689315A4 (en) Care bed
DK3648723T3 (da) Plejeseng
DK3873432T3 (da) Tetracyclinkomplekser med vedvarende aktivitet
EP3785686C0 (en) DELIVERY TABLE
HUE065924T2 (hu) Rögzített ágy elrendezés
EP3809918C0 (en) FURNITURE SET
EP3651711C0 (en) Healthcare bed
EP4058414A4 (en) Faucet assembly
PL3772946T3 (pl) Kompozycja o aktywności przeciwdrobnoustrojowej
ES1221154Y (es) Equipo salvavidas
DK3484852T3 (da) Benzo-n-hydroxyamidforbindelser med antitumor-aktivitet
EP4076741C0 (en) COMPLEXES
PT3873432T (pt) Complexos de tetraciclina com atividade prolongada
EP4077271C0 (en) BOPTA CALCIUM COMPLEX
EP4055230C0 (en) CONSTRUCTION SET
DE112020003471A5 (de) Sitzanordnung
EP3750992A4 (en) NUCLEOSIDASE AGENT WITH REDUCED CONTAMINANT ACTIVITY
EP3936266A4 (en) STRUCTURE
JP1657235S (ja) 椅子